Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies

Busulfan (Bu)-containing regimens are commonly used in myeloablative regimens prior to allogeneic hematopoietic cell transplantation (HCT). Yet, there is considerable variability on how Bu is administered related to frequency (four times a day, Q6 or daily, Q24) and the combination with other chemot...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Biol Blood Marrow Transplant
Главные авторы: Pasquini, Marcelo C., Le-Rademacher, Jennifer, Zhu, Xiaochun, Artz, Andrew, DiPersio, John, Fernandez, Hugo, Mineishi, Shin, Kamishohara, Masaru, Mehta, Jayesh, Nakamura, Yuki, Ratanatharathorn, Voravit, Sobecks, Ronald, Burkart, Jeanne, Bredeson, Christopher
Формат: Artigo
Язык:Inglês
Опубликовано: 2016
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4949158/
https://ncbi.nlm.nih.gov/pubmed/27154848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.04.013
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы